Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature
DiscussionArchived FFPE samples could be successfully assayed by the NanoString nCounter. The purposed signature was prognostic stratifying breast cancer patients into groups with distinct survival patterns, and clinical applicability of the residual risk model was proved.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Genetics | Nanotechnology | Study | Taiwan Health